Although the MAP-kinase cascade is a mutational target in several tumor entities, activation of this pathway by mutations in either GNAQ or GNA11 is specific for uveal melanomas and other nonepidermic melanocytic lesions like blue nevi 19,20,21. This evidence concerns the gene GNAQ and uveal melanoma.